p21 gene polymorphisms in systemic lupus erythematosus

Rheumatology

Volumn 46, Issue 2, 2007, Pages 220-226

  Kong, E K P ^a   Chong, W P ^a   Wong, W H S ^a   Lau, C S ^a   Chan, T M ^a   Ng, P K M ^a   Song, Y Q ^a   Mak, W ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Haplotype; p21; Single nucleotide polymorphism; SLE; Susceptibility

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; MESSENGER RNA;

ADULT; ARTHRITIS; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER;

EID: 33846683738     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel210     Document Type: Article

References (30)

1. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-16.
2. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4.
3. Gartel AL, Serfas MS, Tyner AL. p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med 1996;213:138-49.
4. Harada K, Ogden GR. An overview of the cell cycle arrest protein, p21 (WAF1). Oral Oncol 2000;36:3-7.
5. Santiago-Raber ML, Lawson BR, Dummer W et al. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol 2001;167:4067-74.
6. Li R, Waga S, Hannon GJ, Beach D, Stilman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 1994;371:534-7.
7. El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
8. Sangfelt O, Erickson S, Castro J et al. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Oncogene 1999;18:2798-810.
9. Hobeika AC, Etienne W, Torres BA, Johnson HM, Subramaniam PS. IFN-γ induction of p21 (WAF1) is required for cell cycle inhibition and suppression of apoptosis. Interferon Cytokine Res 1999;19: 1351-61.
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/ WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995;82:675-84.
11. McDonald ER 3rd, Wu GS, Waldman T, El-Deiry WS. Repair defect in p21 WAF1/CIP1 -/- human cancer cells. Cancer Res 1996; 56:2250-5.
12. Bouneaud C, Kourilsky P, Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: A large fraction of T cell clones escapes clonal deletion. Immunity 2000;13:829-40.
13. Balomenos D, Martin-Caballero J, Garcia MI et al. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat Med 2000;6:171-6.
14. Lawson BR, Baccala R, Song J, Croft M, Kono DH, Theofilopoulos AN. Deficiency of the cyclin kinase inhibitor p21 (WAF-1/CIP-1) promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity. J Exp Med 2004;16:547-57.
15. Gaffney PM, Kearns GM, Shark KB et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998;95:14875-9.
16. Gaffney PM, Ortmann WA, Selby SA et al. Genome screening in human systemic lupus erythematosus: Results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am J Hum Genet 2000;66:547-56.
17. Ho CY, Wong CK, Li EK, Tam LS, Lam CW. Expression of cyclin B1 and cyclin dependent kinase inhibitor p21 in lymphocytes in patients with systemic lupus erythematosus. J Rheumatol 2002;29: 2537-44.
18. Perlman H, Bradley K, Liu H et al. IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts. J Immunol 2003; 170:838-45.
19. Santiago-Raber ML, Lawson BR, Dummer W et al. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol 2001;167: 4067-74.
20. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of SLE. Arthritis Rheum 1997; 40:1725.
22. Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM, Alarcon-Riquelme M, Lau YL. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 2005;52:1058-62.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-delta delta C(T). Method 2001;25:402-8.
24. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994;54:3391-5.
25. Herkel J, Mimran A, Erez N et al. Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies. J Autoimmun 2001;17:63-9.
26. Hiyama H, Iavarone A, Reeves SA. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 1998;16: 1513-23.
27. Chakravarti A. Population genetics - making sense out of sequence. Nat Genet Suppl 1999;21:56.
28. Gordon D, Finch SJ, Nothnagel M, Ott J. Power and sample size calculations for case-control genetic association tests when errors are present: Application to single nucleotide polymorphisms. Hum Hered 2002;54:22-33.
29. Gordon D, Ott J. Assessment and management of single nucleotide polymorphism genotype errors in genetic association analysis. Pac Symp Biocomput 2001;6:18-29.
30. Huizinga TWJ, Pisetsky DS, Kimberly RP. Associations, populations, and the truth. Arthritis Rheum 2004;50:2066-71.